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Ischemic preconditioning (IPC) has emerged as a potential non-invasive ergogenic aid to 
enhance exercise performance. Repeated application of IPC has demonstrated clinical efficacy, 
therefore our aims were to investigate its effect on endurance cycling performance and muscle 
efficiency. Twenty participants undertook 7-d repeated bilateral lower limb occlusion (4 x 5-
min) of IPC (220 mmHg) or sham (20 mmHg). Prior to and 72-h following the intervention, 
participants performed submaximal cycling at 70, 80 and 90 % of ventilatory threshold (VT) 
followed by an incremental exercise test. IPC had no effect on ?̇?O2max (P = 0.110); however, 
time to exhaustion increased by ~ 9 % and Wmax by ~ 5 % (IPC pre 307 ± 45 to post 323 ± 51 
W) relative to sham (P = 0.002). There were no changes in gross efficiency (GE) (P > 0.05); 
however, delta efficiency (DE) increased by 3.1 % following IPC (P = 0.011). 
Deoxyhaemoglobin (HHb) was reduced following IPC ~ 30% (P = 0.017) with no change in 
total haemoglobin (tHb). Repeated IPC over 7-d enhanced muscle efficiency and extended 
cycling performance. The physiological effects of repeated IPC on skeletal muscle efficiency 
explains the notable improvements in endurance performance. 
 
 






Ischemic preconditioning (IPC), involving intermittent cessation of blood flow followed by 
reperfusion, has emerged as a potential non-invasive ergogenic aid to enhance exercise 
performance (de Groot et al. 2010) and improve cardiovascular health (Thijssen et al. 2016). 
In tests of endurance (continuous exercise >100 s), the acute application of IPC has conferred 
beneficial effects, enhancing exercise capacity or performance in the range of 2 to 16 % (de 
Groot et al. 2010; Crisafulli et al. 2011; Bailey et al. 2012b; Kido et al. 2015; Cruz et al. 2015; 
Cocking et al. 2018). However, a number of studies have also reported no benefits of IPC on 
endurance performance (< 2 %) (Clevidence et al. 2012; Tocco et al. 2015; Sabino-Carvalho 
et al. 2017; Kilding et al. 2018). Whilst the mechanisms underlying the ergogenic properties 
of IPC are unclear inter-individual variability in the response to IPC has been reported, with a 
responder rate of ~67 % across 17 individual performance studies (Incognito et al. 2016), which 
may explain the inconsistencies reported. 
 
Repeated application of IPC across a number of days, thereby increasing the stimulus, has 
demonstrated clinical efficacy in a dose-dependent manner (Yamaguchi et al. 2015). While a 
small number of studies have examined the repeated application of IPC on exercise 
performance (Foster et al. 2014; Lindsay et al. 2017, 2018), there has been no investigation of 
the associated physiological adaptations that might support an ergogenic effect. For example, 
notable improvements in systolic and diastolic blood pressure (Jones et al. 2014), vascular 
health (Jones et al. 2014) and skeletal muscle oxidative function (Jeffries et al. 2018), if 
translated to the exercising muscle, could enhance the efficiency of ATP turnover and increase 
blood flow, leading to improved tissue oxygenation and metabolite removal.  
 
During repeated IPC, brief periods of ischemia increase oxidative stress (Yellon and Downey 
2003), tissue hypoxia and muscle acidity (Sundberg and Kaijser 1992), whereas during 
reperfusion, the resultant hyperemic response increases sheer-stress on the vasculature (Tinken 
et al. 2010), which combine to initiate local muscle and vascular adaptations. IPC has been 
reported to protect against glycogen depletion (Lintz et al. 2013), reduce lactate production 
(Bailey et al. 2012b) and enhance oxidative function (Jeffries et al. 2018), whereby energy 
metabolism is favourably reduced during subsequent periods of ischemia (Addison et al. 2003). 
We have previously reported enhanced oxidative function following repeated IPC (Jeffries et 
al. 2018), leading us to speculate that adaptations in mitochondrial function may have occurred 
5 
 
(Jeffries et al. 2018). Indeed, IPC is effective in restoring mitochondrial dysfunction in skeletal 
muscle (Thaveau et al. 2007) and can modulate expression of electron transport chain proteins 
in myocardial tissue, thus improving mitochondrial efficiency (Cabrera et al. 2012). Although 
much of the mechanistic underpinnings remain to be explored during dynamic exercise, 
enhanced muscle oxidative properties are evident via accelerated muscle deoxygenation 
kinetics (Kido et al. 2015; Jeffries et al. 2018) and improved maintenance of muscle 
oxygenation (Patterson et al. 2015). While the potential for improved energy metabolism and 
muscle efficiency has recently been explored following acute application of IPC (Kilding et al. 
2018), it is currently unknown whether repeated applications can elicit dose-dependent 
improvements in these critical endurance performance determinants.   
 
The aim of this study was to investigate the effects of 7-d of repeated lower-limb IPC on 
endurance cycling performance, as well as evaluating changes in metabolic responses, 
efficiency and muscle oxygenation during exercise. Based on our above reasoning we 
hypothesized that relative to a sham control, 7-d repeated IPC would (i) improve cycling time 
to exhaustion, (ii) reduce oxygen extraction during submaximal exercise and, (iii) reduce the 









Material and Methods  
 
Participants 
Twenty healthy male participants volunteered to take part in this study (age 21 ± 2 years; height 
181 ± 7 cm; body mass 84 ± 16 kg, ?̇?O2max 45.0 ± 5.9 ml·kg-1·min-1) (Table 1). All participants 
were recreationally active and participated in university level team sports. They were non-
smokers and not taking any medications. A-priori sample size was calculated using G*Power 
(Version 3.1.9.3). This was calculated according to changes in ?̇?O2max 48-h post 7-d repeated 
IPC intervention [9.5 % increase; P < 0.01, d = 0.91, n = 18] (Lindsay et al. 2017). A minimum 
of eight participants per group was deemed a sufficient sample size in order to yield a power 
of 0.95 and α = 0.05. A total of 20 participants were recruited to account for the possibility of 
dropout. Participants were asked to refrain from alcohol and caffeine consumption for 24-h and 
avoid strenuous exercise for 48-h prior to testing. Participants were told to maintain their 
current training regime for the duration of the study. All participants gave written informed 
consent. Ethical approval was provided by the institutional university ethics committee, which 
was conducted in accordance with the 1964 Helsinki declaration. 
Experimental design 
A randomized, single-blind, crossover design was adopted to examine the effect of IPC on 
cycling performance. Participants were assigned to an IPC or sham group using block 
randomization for groups of four participants at a time using online software (Research 
Randomizer (Version 4.0)) (Urbaniak and Plous 2015). Participants first visited the laboratory 
to provide informed consent, conduct baseline tests to determine the first ventilatory threshold 
(VT) and ?̇?O2max (reported in table 1) and to familiarise with the IPC procedure used in the 
experimental trials. For the main experimental trial, participants reported to the laboratory on 
nine separate occasions, across 11 consecutive days. All trials were conducted at the same time 
of day to eliminate circadian variation. 
Test of maximal aerobic capacity 
All cycling exercise was performed on an electronically braked cycle ergometer (Excalibur 
Sport, Lode, Groningen, Netherlands). The cycling setup was recorded on the first baseline 
visit and replicated for subsequent visits. During visit one (baseline testing), participants 
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undertook an incremental exercise test to volitional exhaustion to determine  ?̇?O2max. 
Participants performed a 5-min warm-up at 80 W and selected their preferred cadence (85 ± 5 
r∙min-1) which was then maintained for the duration of the study. The test started at 120 W and 
workload increased by 30 W·min-1 until volitional exhaustion. Expired gases were collected 
and measured using breath-by-breath expired air analysis (OxyCon Pro, Erich Jaeger GmbH, 
Hoechberg, Germany) with the highest average 30-s reported as ?̇?O2max. Achievement of 
?̇?O2max was considered as the attainment of at least two of the following criteria: (1) a plateau 
in ?̇?O2 despite increasing workload; (2) respiratory exchange ratio (RER) above 1.15; and (3) 
heart rate (HR) ± 10 beats∙min−1 of predicted maximum HR calculated as 220-age (Howley et 
al. 1995). Wmax was recorded as the highest power output averaged over 30-s recorded during 
the test and time to exhaustion was also recorded. Heart rate (HR) was recorded continuously 
throughout the trials (Polar Team System®, Polar UK). B[La] was measured 2-min post-test 
completion. The gas analyser was calibrated before every trial with gases of known 
concentration (15.95% O2, 4.97% CO2, BAL. N2) and the turbine volume transducer was 
calibrated using a 3 L syringe (Hans Rudolph, Kansas City, USA). All subsequent  ?̇?O2max tests 
(visit 2 and visit 10) were performed in this way.  Breath-by-breath ?̇?O2 and ?̇?CO2 data from 
the incremental cycling test was used to plot ventilatory threshold (VT) using the simplified v-
slope method (Schneider et al. 1993). From the determined VT, power outputs equating to 70 
%, 80 % and 90 % of VT were calculated for subsequent exercise intensities to determine 
measures of cycling efficiency. Incremental ramp tests were performed at least one week prior 
to commencing the intervention protocol.  
 
Determination of cycling efficiency 
 
During visit 2 (pre-test) and visit 10 (post-test +72-h), participants exercised continuously at 
work rates of 70%, 80% and 90% of VT. Work rates were maintained for 5-min stages followed 
by 3-min rest periods (no pedalling). HR, B[La] and RPE were measured at the end of each 5-
min period. ?̇?O2 and RER were averaged during the final 30-s period of each stage and related 
to work rate. Gross cycling efficiency (GE) was calculated as the ratio of work accomplished 
(W converted to kcal·min-1) to energy expended (kcal·min-1). Energy expenditure (EE) was 
calculated from ?̇?O2 and RER using the tables of Lusk (Lusk 1928). Delta efficiency (DE) was 
calculated as the reciprocal of the linear regression constant on an energy expended versus 
work rate plot (Coyle et al. 1992; Moseley and Jeukendrup 2001). Within-subject CV for 
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measures of absolute GE and DE are reported as 0.8 GE% and 1.7 DE%, respectively (Moseley 
and Jeukendrup 2001). After a 10-min rest period, an incremental ramp test was conducted, as 
previously described to examine ?̇?O2max, peak work rate and time to exhaustion (TTE).   
 
 
NIRS device  
 
A near-infrared spectroscopy (NIRS) optode (Portamon, Artinis Medical Systems, Zetten, the 
Netherlands) was placed on the vastus lateralis of the right leg (midway between the greater 
trochanter and the lateral epicondyle of the femur), shaved and secured with an elastic bandage 
(Tiger Tear, Hampshire, UK) to prevent movement and covered with an optically dense black 
material to minimize the intrusion of extraneous light. The vastus lateralis was chosen because 
it is one of the primary muscles active during the power phase of pedalling (Hug and Dorel 
2009). The position of the probe was distal to the placement of the automatic inflation cuffs 
and was marked with indelible ink which was reapplied at regular intervals during the 
intervention protocol to ensure correct placement of the optode during the post intervention 
trial. During continuous cycling stages NIRS signals were obtained using a portable unit 
consisting of 3 channels (Portamon, Artinis Medical Systems, Zetten, the Netherlands). The 
system is a 2-wavelength continuous wave system that simultaneously uses the modified Beer-
Lambert law and spatially resolved spectroscopy methods. Changes in tissue O2Hb, HHb and 
tHb were measured using the differences in absorption characteristics of infrared light at 760 
and 850 nm. Differential path factor (DPF) of 4 was used throughout. NIRS data was connected 
to a computer by Bluetooth for acquisition at 10 Hz. Values for HHb and tHb were reported as 
the delta from baseline (30-s average prior to cycling stage) to the final 30-s of each stage to 
examine the metabolic demands of the exercise bout. The HHb signal which is regarded as 
blood volume insensitive during exercise was therefore used to indicate intramuscular 
oxygenation status (De Blasi et al. 1994). Adipose tissue thickness (ATT) was measured at the 
site of the NIRS optode, in duplicate, to the nearest 0.1 mm using skinfold calipers (Harpenden, 
Burgess Hill, UK).  The average value of skin and subcutaneous tissue thickness for the IPC 
group was 7.9 ± 2.6 mm and for the sham group 8.4 ± 2.5 mm (range of 4.8 - 12.9 mm). This 
was less than half the distance between source and the detector (35 mm). 
 




For the IPC protocol, automatic inflation cuffs (14.5 cm width – Delfi Medical Innovations, 
Vancover, Canada) were placed on the proximal portion of both thighs. The inflatable cuffs 
were connected to a pressure gauge and were automatically inflated to 220 mmHg (IPC) to 
ensure maximum occlusion across all participants (de Groot et al. 2010). The sham group 
experienced a lower pressure (20 mmHg) using the same automatic inflation cuffs. The 
protocol involved 5-min occlusion, followed by 5-min reperfusion, which was repeated four 
times (lasting 40-min) in the supine position. This procedure was repeated for seven 
consecutive days. To ensure the complete occlusion of arterial inflow to the limb, each 
individual had their limb occlusion pressure (LOP) assessed using a Doppler probe (UltraTec 
PD1, Ultrasound Technologies, Caldicot, UK) and automatic inflation cuff, previously 




Data are presented as means ± SD. To adjust for differences at baseline between groups we 
used an analysis of covariance (ANCOVA) (Vickers and Altman 2001) to determine the 
difference between GE, DE, ?̇?O2max, TTE, PO, HHb, tHb, HR, B[La] and RPE. There was one 
independent variable with two levels (IPC vs. sham), with the participants’ pre-test baseline 
data used as a covariate. Magnitude of effects were calculated with partial eta-squared (ηp
2) 
according to the following criteria: 0.02, a small difference; 0.13, a moderate difference; 0.26 
a large difference. Statistical analysis was performed using SPSS 21 (IBM, Armonk, NY). Data 
were presented with GraphPad Prism (GraphPad Software, La Jolla, CA). Statistical 







?̇?O2max was not different following 7-d repeated IPC or sham (IPC pre 44.7 ± 5.1 to post 45.0 
± 5.6 ml∙kg-1∙min-1; sham pre 42.8 ± 7.3 to post 40.6 ± 8.1 ml∙kg-1∙min-1) (F(1, 17) = 2.838, P = 
0.110, ηp
2 = 0.143). However, TTE was extended during the incremental ramp test by ~32-s 
(9%) (IPC pre 373 ± 89 to post 405 ± 103-s; sham pre 351 ± 67 to post 344 ± 69-s) (F(1, 17) = 
16.116, P = 0.001, ηp
2 = 0.487). All participants in the IPC group increased their exercise 
capacity, with two demonstrating a change < 5-s, and the remainder ranging from (22 – 63-s) 
(Figure 1a). Participants achieved a ~ 5 % increase in Wmax output (IPC pre 307 ± 45 to post 
323 ± 51 W; sham pre 295 ± 31 to post 292 ± 35 W) (F(1, 17) =imitaiton 12.610, P = 0.002, ηp
2 
= 0.426) (Figure 1b). Maximal HR was moderately increased (IPC pre 193 ± 13 to post 196 ± 
10 b·min-1; sham pre 193 ± 7 to post 187 ± 13 b·min-1) (F(1, 17) = 5.697, P = 0.029, ηp
2 = 0.251), 
along with end B[La] (IPC pre 9.8 ± 3.4 to post 10.8 ± 1.8 mmol-1; sham pre 9.0 ± 1.7 to post 
9.5 ± 1.6 mmol-1) (F(1, 17) = 19.761, P < 0.001, ηp




GE did not differ between conditions at each exercise intensity, 70% VT (F(1, 17) = 0.837, P = 
0.373, ηp
2 = 0.047), 80% VT (F(1, 17) = 3.054, P = 0.099 ηp
2 = 0.152), 90% VT (F(1, 17) = 2.171, 
P = 0.159 ηp
2 = 0.132) (Table 2). However, the moderate effect sizes evident at higher exercise 
intensities (80 & 90% VT) suggest that there could be meaningful increases in the IPC group. 
Observed differences in pre-to-post GE following the IPC intervention were as follows: IPC 
pre-to-post difference: 70 % VT +0.05 %; 80 % VT +0.6 %; 90% VT +0.5%; relative to sham 
pre-to-post difference: 70 % VT +0.3 %; 80 % VT +0.2 %; 90% VT +0.2%) (Table 2). There 
were no differences in B[La] or RPE between conditions (P > 0.05) (Table 3). DE demonstrated 
a main effect between IPC and sham (F(1, 17) = 8.213, P = 0.011, ηp
2 = 0.326) (Figure 2). DE 
increased by 3.1 % from baseline in the IPC group relative to a 0.6 % change in the sham 







IPC reduced delta HHb at exercise intensities of 70% VT (F(1, 16) = 9.610, P = 0.007, ηp
2 = 
0.375), 80% VT (F(1, 16) = 8.634, P = 0.010, ηp
2 = 0.350) and 90% VT (F(1, 16) = 7.038, P = 
0.017, ηp
2 = 0.305) compared to sham (Table 4). In contrast, tHb was not different between 
condition at 70% VT (F(1, 16) = 0.280, P = 0.604, ηp
2 = 0.017), 80% VT (F(1, 16) = 0.169, P = 
0.686, ηp
2 = 0.010) and 90% VT (F(1, 16) = 0.379, P = 0.547, ηp
2 = 0.023). A representative 
figure illustrates no apparent change in tHb (Figure 3a) and a reduction in HHb during each 









The principle findings of this investigation were that following 7-d repeated IPC i) maximal 
exercise performance was improved by +9 %, without any change in ?̇?O2max, ii) DE was 
enhanced by +3.1 % and iii) there was an increase in tissue oxygenation during submaximal 
cycling tasks, with respect to sham. Together, these novel findings indicate that the 
physiological adaptations that occur following repeated IPC on skeletal muscle efficiency 
translate to improvements in endurance performance. 
 
Acute application of IPC is reported to have inconsistent effects in tests of aerobic capacity. 
For example, some have reported no change in ?̇?O2max, despite performance improvements 
(Crisafulli et al. 2011; Bailey et al. 2012a; Kilding et al. 2018), whilst others have reported a 
~3 % increase in ?̇?O2max, alongside improvements in performance (de Groot et al. 2010; Cruz 
et al. 2015). Here, we can confirm that repetitive application of IPC across seven days did not 
confer any further changes to ?̇?O2max. However, repeated IPC did enhance performance power 
(Wmax) by +9 %. These observations were made beyond the late phase (72-h) of IPC-mediated 
protection and, therefore, importantly do not reflect the acute effects of IPC (Yellon and Baxter 
1995; Loukogeorgakis et al. 2005). Whilst there is limited research examining the repeated 
nature of IPC on performance, our findings contrast the +13 % increase in ?̇?O2max reported in 
untrained individuals (?̇?O2max  ~ 39 ml·kg-1·min-1) (Lindsay et al. 2017), but are further 
supported by work from the same group where no change in ?̇?O2max was observed in 
moderately fitter individuals (?̇?O2max  ~ 50 ml·kg-1·min-1), both immediately and 7-d following 
a repeated IPC procedure (Lindsay et al. 2018). Caution should be exercised when interpreting 
the large effects reported, to date, due to potential training effect in the recreational population, 
which was noted by the authors (Lindsay et al. 2017). The changes in performance power 
described are typically explained by increased ?̇?O2max, improvements in lactate threshold 
and/or efficiency (Joyner and Coyle 2008). However, an inverse relationship has been reported 
between training-induced changes in exercise efficiency and ?̇?O2max (Hopker et al. 2012). Thus, 
assuming the generalizability of this phenomenon, improved efficiency could explain the +9 
% increase in Wmax, in the absence of a change in ?̇?O2max.  
 
Efficiency is a measure of work generated, expressed as a percentage of total metabolic energy 
expended (Ettema and Loras 2009) and can provide insight into the metabolic processes 
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involved in work production. Following 7-d repeated IPC, GE appeared to increase as a 
function of intensity by +0.05 %, +0.6 % and +0.5 % at 70, 80 and 90 % VT, respectively 
(Table 2). Whilst these changes were not significant the higher exercise intensities showed 
moderate effect sizes and the increases reported are comparable to increases (+0.8 %) in GE in 
response to altitude training protocols (23-d live high: train low) (Gore et al. 2001) although 
less than those that can be achieved following a 6-week period of high-intensity training (+1.6 
%) (Hopker et al. 2010). GE is known to increase with exercise intensity, representing a 
transition from less-to-more efficient states (Sidossis et al. 1992; Chavarren and Calbet 1999). 
Therefore, optimising mechanical power at higher work intensities may have enabled the 
effects of the IPC intervention to manifest. The small differences described could be related to 
the calculation of GE, which incorporates basal energy costs, the cost of respiratory and 
stabilizing muscles, as well as the internal mechanical work associated with exercise (Moseley 
and Jeukendrup 2001). Indeed there would be a reduced contribution of resting ?̇?O2 to whole-
body ?̇?O2 as muscle contractions increase (Chavarren and Calbet 1999) and, therefore, GE is 
limited by the assumption that these metabolic processes are stable across a range of exercise 
intensities (Ettema and Loras 2009). However, such changes could also be explained by prior 
exercise at 70 % VT, which could have altered the interaction between oxygen delivery (?̇?O2) 
and utilization (m?̇?O2), thus enhancing efficiency in subsequent bouts (Ferreira et al. 2005). It 
is also important to note that the within-subject CV for measures of GE has been reported as 
0.8 GE% (Moseley and Jeukendrup 2001) and, therefore, could also be accounted for by 
measurement error.  
 
The determination of muscle efficiency is better explained by DE (Coyle et al. 1992). DE 
examines the increase in external power and metabolic rate with increasing work rate and is 
less likely to be affected by changes in baseline metabolic processes (Ettema and Loras 2009). 
Therefore, DE may better reflect adaptations to local skeletal muscle, proximal to site where 
IPC was applied. The most striking finding of the present study was a +3.1 % increase in DE 
following 7-d repeated IPC. Indeed, these improvements in muscle efficiency confirm our 
previous work, where resting muscle metabolism was reduced by -16 % following 7-d repeated 
IPC (Jeffries et al. 2018). Whilst smaller changes in DE have been reported following 3-d 
nitrate supplementation (0.8 %) (Larsen et al. 2007), strength training in young cyclists (0.9 
%) (Louis et al. 2012) and 6 weeks high-intensity training (~1 %) (Hopker et al. 2010), 
efficiency is known to differ according to training status and age (Hopker et al. 2013). The 
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participants recruited in this study were young (21 ± 2 y); however, they were untrained 
(V̇O2max 45.0 ± 5.9 ml·kg-1·min-1) and hence may have a greater capacity for improvement. 
Among older athletes, where baseline measures of DE are reduced (~ 2 %) compared to 
younger athletes, a 3-week strength training programme achieved a +3.2 % increase in DE 
(Louis et al. 2012). Thus, the changes reported herein are feasible and most likely reflect the 
training status of the participants recruited. Our findings contrast those reported after acute 
application of IPC, where no changes in running economy (Kaur et al. 2017) or cycling 
economy (Clevidence et al. 2012; Kilding et al. 2018) have been reported. Furthermore, 
increasing the number of ischemic episodes during an acute application (up to 8 x 5-min), 
beyond the traditional 4 x 5-min protocol, elicited no additional improvements in performance 
(Cocking et al. 2018). Therefore, we suggest that repeated application of the IPC stimulus is 
imperative to elicit the longer term adaptations in the skeletal muscle observed in the current 
study and previously (Jeffries et al. 2018), which contribute to improved endurance capacity. 
Indeed, the benefits of repeated IPC are supported by work in animal models that suggest 
greater protection can be achieved against ischemia in a dose-dependent manner (Yamaguchi 
et al. 2015). However, more research is needed in this area to examine the dose-response effect 
of IPC and the minimal stimulus required to achieve these positive adaptations to facilitate 
exercise performance.  
 
Near-infrared spectroscopy enabled further interrogation of ?̇?O2 and m?̇?O2 during the 
submaximal exercise protocols used in this study. The HHb signal, which is regarded as blood 
volume insensitive, is used to report muscle fractional oxygen extraction during exercise (De 
Blasi et al. 1993). Here, across a range of submaximal intensities, we observed a ~ 30 % 
reduction in the HHb signal following 7-d repeated IPC. This reduction suggests an increased 
fraction of oxygen in the muscle, which may represent a reduction in m?̇?O2, ?̇?O2, or a 
combination of these factors. However, tHb which represents the total hemoglobin 
concentration in the tissue (i.e. blood volume), did not significantly increase at higher work 
intensities (Table 4). We have previously established enhanced oxidative capacity and vascular 
improvements in the skeletal muscle following 7-d repeated IPC (Jeffries et al. 2018). Thus, 
enhanced muscular efficiency could result from an improved match between m?̇?O2 and ?̇?O2 
in the skeletal muscle. IPC could therefore optimise the ?̇?O2/m?̇?O2 ratio to improve muscular 




There is considerable heterogeneity in the correlation between ?̇?O2 and m?̇?O2, particularly in 
untrained individuals (Kalliokoski et al. 2005), suggesting a potential for mismatch between 
oxygen delivery and demand. Indeed, the balance of ?̇?O2/m?̇?O2 is modulated according to the 
metabolic requirements associated with increases in exercise intensity (Okushima et al. 2016). 
By examining the constituents of the Fick equation (m?̇?O2 = ?̇?O2 x [(a-v)O2]), a reduction in 
arteriovenous O2 difference [(a-v)O2] or fractional oxygen extraction as indicated by NIRS, 
could also suggest that adaptations occurred in the muscle itself. Two possible mechanisms 
could explain these changes; a reduction in metabolic rate (reduced ATP requirement) or 
increased mitochondrial efficiency (increased ATP per molecule O2). Indeed, preconditioned 
tissues demonstrate a slower rate of ATP depletion, milder acidosis, and, via the release and 
delivery of vasoactive triggers (VEGF, adenosine, bradykinin, NO), augmented peripheral 
vascular blood flow (Yellon and Downey 2003; Jones et al. 2014) and angiogenesis (Yellon 




There was clear inter-individual variability in the response to IPC during the ?̇?O2max test in the 
current study. Three participants demonstrated negligible improvements in performance time 
< 8 s and Wmax < 8 W and four individuals reported changes > 50 s and > 26 W, with mean 
changes being ~ 31 s and ~ 16 W respectively (Figure 1). These data support a ~ 70 % response 
rate, which aligns with a recent systematic review that reported the IPC responder rate at ~67% 
(Incognito et al. 2016). It should be noted that high responders may have influenced the general 
trends we report. In addition, baseline differences in body mass, ?̇?O2max and Wmax were also 
observed suggesting that collectively the sham group may have had a reduced training status. 
This group showed a small systematic reduction in performance time and Wmax following the 
sham condition, but is unclear why. Although we statistically controlled for differences at 
baseline, it is possible that fitness status could have influenced the ability to respond to the IPC 
stimulus. A greater understanding is required to explore the physiological and psychological 
factors that may predispose an individual to the beneficial effects of IPC, both from a 
performance and clinical perspective. 
 
It should be noted that some concerns exist regarding excessive bouts of IPC, termed 
‘hyperconditioning’, which have been suggested to confer adverse effects at higher doses and 
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would be particularly relevant in susceptible populations (Whittaker and Przyklenk 2014). 
However, when administered as a series of brief occlusions, no side-effects have been reported 
for a single application, nor for repeated applications up to 300 days (Meng et al., 2012). IPC 
also remains an effective technique to elicit cardio-protection in patients undergoing cardiac 




One of the most interesting aspects of the current study is the change in efficiency, without any 
additional training load placed on the participants. IPC is also a simple, non-invasive technique 
that may confer competitive advantage. Furthermore, these changes occur in a short time frame 
(7 days) and, thus, could be utilized by athletes during preparation for competition. Whilst the 
magnitude of improvement may appear small, it could markedly influence performance in 
prolonged cycling. Future studies should consider the underlying mechanisms that support 
these improvements in muscle efficiency and the optimal dose required to elicit performance 
enhancement.    
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Table 1: Participant characteristics. Data are presented as mean ± SD.  
 
Participant characteristics IPC (n = 10) Sham (n = 10) 
Age (y) 22 ± 3 21 ± 2 
Height (cm) 180.4 ± 7.1 181.3 ± 6.3 
Body mass (kg) 80.7 ± 10.3 87.5 ± 20.6 
Baseline ?̇?O2max (ml·kg-1·min-1) 46.0 ± 3.8 43.8 ± 7.6 
Baseline peak power (W) 377 ± 89 296 ± 29 
LOP (mmHg) 201 ± 13 188 ± 10 
 
Participant characteristics are reported from baseline tests. Abbreviations: IPC, ischemic 






















 GE (%)  
            IPC Pre            IPC Post Δ 
70% VT 19.6 ± 1.9 
 
19.6 ± 1.5 
 
0.05 
80% VT 19.4 ± 1.7 
 
20.0 ± 1.6 
 
0.6 
90% VT 19.8 ± 1.6 
 
20.3 ± 1.5 
 
0.5 
 Sham Pre Sham Post  
70% VT 17.6 ± 1.0 
 
17.9 ± 0.9 
 
0.3 
80% VT 17.8 ± 0.8 
 
18.0 ± 0.8 
 
0.2 
90% VT 18.4 ± 0.9 
 





Table 3. Blood lactate concentration (B[La]) and rating of perceived exertion (RPE) during 

















 B[La] RPE 
 IPC Pre IPC Post IPC Pre IPC Post 
70% VT 4.8 ± 1.7 4.9 ± 1.6 12.0 ± 1.7 12.4 ± 1.3 
80% VT 6.5 ± 2.3 6.7 ± 2.3 15.0 ± 1.7 14.8 ± 1.6 
90% VT 7.9 ± 2.9 8.2 ± 2.4 17.4 ± 1.5 17.4 ± 1.6 
 Sham Pre Sham Post Sham Pre Sham Post 
70% VT 4.6 ± 1.3 4.6 ± 1.3 12.0 ± 2.3 11.4 ± 2.2 
80% VT 6.3 ± 1.8 5.9 ± 1.4 14.3 ± 1.2 14.6 ± 1.6 
90% VT 8.1 ± 2.1 7.8 ± 1.7 16.5 ± 1.5 16.7 ± 1.3 
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Table 4. Delta changes in deoxyhaemoglobin (HHb) and total haemoglobin (tHb) during 




Values are presented as mean ± SD. HHb, deoxygenated haemoglobin; tHb, total haemoglobin; 
a.u., auxillary units; VT ventilatory threshold. Δ represents the delta between pre and post 
measures * P < 0.05 post intervention differences from baseline. 
  
 [HHb] delta (a.u.)  [tHb] delta (a.u)  
 IPC Pre   IPC Post Δ IPC Pre IPC Post Δ 
70% VT 7.17 ± 5.12 4.87 ± 4.55  * -2.3 -1.73 ± 8.27 -1.39 ± 5.85 -0.3 
80% VT 7.78 ± 4.86 4.88 ± 3.76  * -2.9 0.95 ± 7.81 1.03 ± 5.30 0.1 
90% VT 7.76 ± 4.76 5.91 ± 3.96  * -1.9 0.33 ± 7.87 1.20 ± 4.38 0.9 
 Sham Pre Sham Post  Sham Pre Sham Post  
70% VT 7.93 ± 4.27 7.67 ± 3.75  -0.26 -0.52 ± 6.34 -0.31 ± 5.90 -0.2 
80% VT 8.89 ± 4.81 8.24 ± 3.85 -0.65 2.26 ± 6.62 2.56 ± 6.09 0.3 





Figure 1. The change in a) time to exhaustion (TTE) and b) peak power output (Wmax) during 
an incremental ramp test following 7-d repeated IPC or sham (n = 20). * P < 0.05. 
 
Figure 2. Percent change in pre-to-post delta efficiency (DE) following 7d IPC or sham. ** P 
= 0.011. 
 
Figure 3. Representative exercise protocol showing cycling stages at 70% VT, 80% VT and 
90% VT. Data shown is from NIRS HHb and presented as pre (BLACK) and post (GREY) 7-
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